Data / Form D filings / InterAct Therapeutics, Inc.
InterAct Therapeutics, Inc.: Form D filing
InterAct Therapeutics, Inc., a health care company in Dallas, TX, filed a Form D with the SEC in 2026. The latest, on July 21, 2026, reports $250,000 sold of a $2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3060 PEGASUS PARK DRIVE BUILDING 6, Dallas, TX, 75247
- Phone
- (210) 710-2867
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2107143
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | New notice | $2,000,000 | $250,000 | $1,750,000 | 1 | Jul 20, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Hargrove | Executive Officer, Director | Mr. Hargrove is the CEO and a director of the Issuer. |
| Isaac Chan | Director | Dr. Chan is a director of the Issuer |
Other health care companies in Texas that filed recently
- Teos Health, LLC $3.1 million · Oct 30, 2026
- Tenora Studios, LLC $1.5 million · Oct 30, 2026
- Cosmetic Physician Partners, LLC $204,284 · Oct 14, 2026
- TMF1 Akido, LLC offering · Oct 9, 2026
- Surgical Caregivers of Fort Worth, LLC offering · Oct 9, 2026
- Pressio, Inc. $543,850 · Oct 6, 2026
Every Form D from the week of Jul 20, 2026 · All recent filings in Texas · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what InterAct Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.